Literature DB >> 16713977

Carbon monoxide orchestrates a protective response through PPARgamma.

Martin Bilban1, Fritz H Bach, Sherrie L Otterbein, Emeka Ifedigbo, Joana de Costa d'Avila, Harald Esterbauer, Beek Yoke Chin, Anny Usheva, Simon C Robson, Oswald Wagner, Leo E Otterbein.   

Abstract

Carbon monoxide (CO) suppresses proinflammatory responses in macrophages reacting to LPS. We hypothesize that CO acts by inducing a molecule(s) that suppresses the inflammatory response to subsequent stress. Exposure of macrophages to CO alone in vitro produced a brief burst of mitochondrial-derived ROS, which led to expression of PPARgamma. PPARgamma expression proved essential for mediating the anti-inflammatory effects of CO. Blocking the CO-mediated increase in ROS generation prevented PPARgamma induction, and blocking PPARgamma prevented CO's anti-inflammatory effects. In a model of acute lung injury in mice, CO blocked expression of Egr-1, a central mediator of inflammation, and decreased tissue damage; inhibition of PPARgamma abrogated both effects. These data identify the mitochondrial oxidases as an (perhaps the) initial cellular target of CO and demonstrate that CO upregulates expression of PPARgamma via the mitochondria, which assures that a subsequent stress stimulus will lead to a cytoprotective as opposed to a proinflammatory phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16713977     DOI: 10.1016/j.immuni.2006.03.012

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  64 in total

Review 1.  Use of carbon monoxide in minimizing ischemia/reperfusion injury in transplantation.

Authors:  Kikumi S Ozaki; Shoko Kimura; Noriko Murase
Journal:  Transplant Rev (Orlando)       Date:  2011-10-13       Impact factor: 3.943

2.  Activation of PPAR-gamma by carbon monoxide from CORM-2 leads to the inhibition of iNOS but not COX-2 expression in LPS-stimulated macrophages.

Authors:  Konstantin Tsoyi; Yu Mi Ha; Young Min Kim; Young Soo Lee; Hyo Jung Kim; Hye Jung Kim; Han Geuk Seo; Jae Heun Lee; Ki Churl Chang
Journal:  Inflammation       Date:  2009-12       Impact factor: 4.092

3.  Genome-wide profiling of in vivo LPS-responsive genes in splenic myeloid cells.

Authors:  Myeong Sup Lee; Byungil Kim; Sun-Min Lee; Woo-Cheul Cho; Wook-Bin Lee; Ji-Seon Kang; Un Yung Choi; Jaemyun Lyu; Young-Joon Kim
Journal:  Mol Cells       Date:  2013-05-10       Impact factor: 5.034

Review 4.  Therapeutic potential of HO-1 in autoimmune diseases.

Authors:  Bao-Zhu Li; Biao Guo; Hai-Yan Zhang; Juan Liu; Sha-Sha Tao; Hai-Feng Pan; Dong-Qing Ye
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

Review 5.  Carbon monoxide in exhaled breath testing and therapeutics.

Authors:  Stefan W Ryter; Augustine M K Choi
Journal:  J Breath Res       Date:  2013-02-27       Impact factor: 3.262

Review 6.  Carbon monoxide in lung cell physiology and disease.

Authors:  Stefan W Ryter; Kevin C Ma; Augustine M K Choi
Journal:  Am J Physiol Cell Physiol       Date:  2017-11-08       Impact factor: 4.249

7.  Carbon monoxide protects against ventilator-induced lung injury via PPAR-gamma and inhibition of Egr-1.

Authors:  Alexander Hoetzel; Tamas Dolinay; Simone Vallbracht; Yingze Zhang; Hong Pyo Kim; Emeka Ifedigbo; Sean Alber; A Murat Kaynar; Rene Schmidt; Stefan W Ryter; Augustine M K Choi
Journal:  Am J Respir Crit Care Med       Date:  2008-03-20       Impact factor: 21.405

8.  Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice.

Authors:  Timothy D Wiggin; Matthias Kretzler; Subramaniam Pennathur; Kelli A Sullivan; Frank C Brosius; Eva L Feldman
Journal:  Endocrinology       Date:  2008-06-26       Impact factor: 4.736

9.  Carbon monoxide blocks lipopolysaccharide-induced gene expression by interfering with proximal TLR4 to NF-kappaB signal transduction in human monocytes.

Authors:  Maneesha Chhikara; Shuibang Wang; Steven J Kern; Gabriela A Ferreyra; Jennifer J Barb; Peter J Munson; Robert L Danner
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

Review 10.  Bench-to-bedside review: Carbon monoxide--from mitochondrial poisoning to therapeutic use.

Authors:  Inge Bauer; Benedikt H J Pannen
Journal:  Crit Care       Date:  2009-08-14       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.